Physician

Mihail Ion Soare, M.D.

According to 2025 Medicare claims, Mihail Soare, M.D. (NPI: 1194906859) practices nephrology in the Bangor, ME market, with the plurality of this provider's patient population coming from Penobscot, ME. This provider's primary affiliated billing organization is NORTHEAST NEPHROLOGY PA (NPI: 1336145200; TIN: 01-0521643) and primary practice location at 04401-6614. Soare is affiliated with the Community Care Partnership of Maine, LLC (ACO ID: A2831) and Beacon Rural Health, LLC (ACO ID: A5614), participating under the MSSP model.

Soare's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 355 traditional Medicare patients, billed 985 HCPCS/CPT codes, and received $122,235 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 766 prescription claims across 175 beneficiaries totaling $568,225 in drug costs, led by Xphozah (Tenapanor Hcl). DME data shows 53 claims. Open Payments data shows 1 records totaling $60. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $279,876 and ending at $568,225. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	597	1,658	$139,237
2016	616	1,824	$154,952
2017	595	1,728	$177,876
2018	586	1,882	$253,249
2019	596	1,972	$201,443
2020	568	1,959	$204,208
2021	508	1,639	$212,224
2022	447	1,477	$172,194
2023	321	913	$109,730
2024	355	985	$122,235

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	232	1,289	$279,876
2016	261	1,526	$495,791
2017	262	1,306	$481,499
2018	234	955	$182,997
2019	193	850	$115,962
2020	201	872	$120,336
2021	208	850	$186,561
2022	189	770	$199,498
2023	184	723	$281,221
2024	175	766	$568,225

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	167	$10,971
2016	N/R	146	$7,797
2017	N/R	162	$6,476
2018	N/R	71	$3,595
2019	N/R	140	$4,608
2020	N/R	133	$4,349
2021	N/R	111	$2,794
2022	N/R	26	$354
2023	N/R	51	$1,551
2024	N/R	53	$1,736

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	105	191	$259
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	48	72	$214
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	42	42	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	76	101	$79
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	116	395	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xphozah	Tenapanor Hcl	119	3,750	$346,383
Farxiga	Dapagliflozin Propanediol	39	3,402	$59,967
Velphoro	Sucroferric Oxyhydroxide	20	900	$59,318
Lokelma	Sodium Zirconium Cyclosilicate	42	1,428	$29,013
Jardiance	Empagliflozin	27	857	$16,103

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7515	Cyclosporine, oral, 25 mg	N	N/R	12	$1,185
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	16	$201
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	13	$125

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$60	Outset Medical Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mihail Ion Soare, M.D.?

Tedicare shows public-source Medicare data for Mihail Ion Soare, M.D. (NPI 1194906859), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mihail Ion Soare, M.D. have ACO affiliation data?

Mihail Ion Soare, M.D. is shown with ACO affiliation data for Community Care Partnership of Maine, LLC (MSSP, ACO ID A2831) and Beacon Rural Health, LLC (MSSP, ACO ID A5614).

What billing organization is linked to Mihail Ion Soare, M.D.?

Mihail Ion Soare, M.D. is linked to NORTHEAST NEPHROLOGY PA (billing NPI 1336145200) in the available physician profile data.

Does Mihail Ion Soare, M.D. have Open Payments data?

Mihail Ion Soare, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.